BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20540007)

  • 1. Editorial: Endocrine regulation of mineral ions and their relevance to metabolic diseases.
    Hartman ML; Razzaque MS
    Front Endocrinol (Lausanne); 2024; 15():1391096. PubMed ID: 38633752
    [No Abstract]   [Full Text] [Related]  

  • 2. Centering Symptom Burden in Patient-Oriented Clinical Trials in Kidney Disease.
    Nair D
    Kidney360; 2023 Sep; 4(9):e1196-e1198. PubMed ID: 37768808
    [No Abstract]   [Full Text] [Related]  

  • 3. Time to Abandon Renalism: Patients with Kidney Diseases Deserve More.
    Gaut JP
    Clin J Am Soc Nephrol; 2023 Apr; 18(4):419-420. PubMed ID: 36913251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].
    Houillier P;
    Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [KDIGO on CKD-MBD: a new classification for an old problem?].
    Cozzolino M
    G Ital Nefrol; 2009; 26(6):645. PubMed ID: 19918741
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in bone and mineral metabolism in kidney transplant patients with chronic kidney disease].
    López Oliva MO; Del Castillo Caba D; Sánchez Plumed J
    Nefrologia; 2009; 29 Suppl 1():31-7. PubMed ID: 19675659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?].
    Limardo M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2010; 27(3):211-4. PubMed ID: 20540007
    [No Abstract]   [Full Text] [Related]  

  • 9. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). KDIGO CKD-MBD Clinical Practice Guideline].
    Tsukamoto Y
    Clin Calcium; 2010 Jul; 20(7):1021-7. PubMed ID: 20585180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
    Orita H; Akizawa T
    Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.